Hofseth BioCare ASA
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HOFBF research report →
Price Chart
About the company
Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The company offers a diverse array of products.
- CEO
- Jon Olav Odegard
- IPO
- 2018
- Employees
- 84
- HQ
- Ålesund, MR, NO
Get TickerSpark's AI analysis on HOFBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $68.47M
- P/E
- -4.04
- PEG
- 4.22
- P/S
- 2.33
- P/B
- -18.07
- EV/EBITDA
- -11.84
- Div Yield
- 0.00%
- Gross Margin
- -6.67%
- Op Margin
- -48.27%
- Net Margin
- -57.40%
- ROE
- 224.31%
- ROIC
- -37.38%
Latest fiscal year · YoY change
- Revenue
- $254.29M-1.2%
- Gross Profit
- $-32,453,669-136.9%
- Op Income
- $-112,623,396
- Net Income
- $-134,804,867-9.2%
- EPS
- $-0.33-10.0%
- OCF Growth
- -291.3%
- FCF Growth
- -358.7%
- 52W High
- $0.18
- 52W Low
- $0.17
- 50D MA
- $0.17
- 200D MA
- $0.17
- Beta
- 0.26
- RSI (14)
- 100
- Avg Volume
- 42.00K
No earnings-call transcripts are available for HOFBF yet.
- Free Float
- 50.1%
- Shares Outstanding
- 411.00M
- Float Shares
- 205.83M
Our HOFBF coverage
Recent articles, reports, and earnings notes.
No research on HOFBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HOFBF report →Hofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2026
globenewswire.com · Jun 9
Hofseth BioCare ASA: EXCLUSIVE LICENSE AND SUPPLY AGREEMENT SIGNED FOR PROGO FOR OVER $5M
globenewswire.com · May 21
Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas
globenewswire.com · Apr 14
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025
globenewswire.com · Mar 27
Hofseth BioCare ASA: FOURTH QUARTER 2025 FINANCIAL REPORT
globenewswire.com · Feb 13
Hofseth BioCare ASA: PRIMARY INSIDER NOTIFICATION
globenewswire.com · Nov 21
Hofseth BioCare ASA: RESULTS OF SUBSEQUENT OFFERING
globenewswire.com · Nov 21
Hofseth BioCare ASA: Extraordinary General Meeting completed
globenewswire.com · Nov 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.